Dr. magali gary-bobo, Biomolecules, Women Researcher Award

Doctorate at IBMM, France

Professional Profile

Scopus

Orcid

🌟Summary

  • Dr. magali gary-bobo is a distinguished researcher specializing in biomolecules and nanotechnology, renowned for her contributions to cancer therapy and gene delivery systems. She holds a HDR from the University of Montpellier and serves as CR1 at the IBMM. Magali excels in both academic leadership and industry collaboration, co-founding NanoMedSyn and co-inventing multiple patents.

📚 Education

  • HDR, University of Montpellier, 2014
  • PhD, University of Montpellier, 2006

👩‍🔬 Professional Experience

    • 2016-Present: CR1 (Directeur de Recherche de Première Classe) at Institut des Biomolécules Max Mousseron (IBMM), under Pascal Dumy.
    • 2012-2016: CR2 (Directeur de Recherche de Deuxième Classe) at IBMM, under Jean Martinez.

🔍 Research Interests

  • Nanoplatforms for cancer therapy: 🧬🔬🩸
  • Gene delivery systems: 🧬💉
  • Nanovectors for therapeutic targeting: 🎯💊

👩‍💼 Administrative Responsibilities

  • Co-leader, “Glyco and Nanovectors for Therapeutic Targeting” team
  • Member of various scientific committees and boards

🏆 Honors and Activities

  • Guest editor for multiple special issues in scientific journals
  • Organizer and speaker at international conferences

Publication Top Noted📝

  • Article: Nanoencapsulation of a Far-Red Absorbing Phthalocyanine into Poly(benzylmalate) Biopolymers and Modulation of Their Photodynamic Efficiency
    • Authors: Şahin, Z., Önal, E., Ali, L.M.A., Cammas-Marion, S., Dumoulin, F.
    • Journal: Biomacromolecules
    • Volume: 25
    • Issue: 6
    • Pages: 3261–3270
    • Year: 2024
  • Article: Therapeutic antibody engineering for efficient targeted degradation of membrane proteins in lysosomes
    • Authors: Gauthier, C., Daurat, M., Ali, L.M.A., Maynadier, M., Basile, I.
    • Journal: Biomedicine and Pharmacotherapy
    • Volume: 175
    • Pages: 116707
    • Year: 2024
  • Article: Exceptional anticancer photodynamic properties of [1,4-Bis(3,6,9,12-Tetraoxatridec-1-yloxy)phthalocyaninato]zinc(II)
    • Authors: Nguyen, C., Toubia, I., Hadj-Kaddour, K., Odobel, F., Gary-Bobo, M.
    • Journal: Journal of Photochemistry and Photobiology B: Biology
    • Volume: 253
    • Pages: 112863
    • Year: 2024
  • Article: Probing the Use of Triphenyl Phosphonium Cation for Mitochondrial Nucleoside Delivery
    • Authors: Guiraud, M., Ali, L.M.A., Gabrieli-Magot, E., Gary-Bobo, M., Peyrottes, S.
    • Journal: ACS Medicinal Chemistry Letters
    • Volume: 15
    • Issue: 3
    • Pages: 418–422
    • Year: 2024
  • Article: Thiochromenocarbazole imide-based photosensitizers decorated with carbonic anhydrase inhibitors for the targeted treatment of hypoxic tumours
    • Authors: Merabti, A., Sánchez, D.P., Nocentini, A., Winum, J.-Y., Clément, S.
    • Journal: Materials Advances
    • Volume: 5
    • Issue: 10
    • Pages: 4172–4177
    • Year: 2024
Dr. magali gary-bobo, Biomolecules, Women Researcher Award